Longitudinal Care: Smoking Reduction to Aid Cessation

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether an extended care treatment model lasting over a year will increase long-term smoking cessation rates compared to the standard 8 week treatment of care.

Clinical Trial Description

Objective The objective of this project is to conduct a randomized controlled trial to compare 1) an extended quality care smoking cessation treatment delivered over a one-year period (EQC) to 2) quality care smoking cessation treatment delivered over an 8 week period (QC) to determine if EQC improves prolonged smoking abstinence.

Research Design/Methodology 500 smokers who are interested in quitting will be enrolled and randomly assigned to the EQC or QC groups. Both groups will initially receive a state-of-the-science smoking cessation intervention including behavioral and pharmacological components, delivered by a combination of in-person and telephone care. EQC participants who fail to quit, reduce but do not quit, or relapse will receive intensive treatment over the ensuing 12 months that encourages repeat quit attempts and smoking reduction if they are not to quit. We propose reduction as an intermediate goal in LC because this may increase the likelihood of cessation, increase self-efficacy and keep smokers and clinicians engaged. Reduction treatment will include behavioral treatment and nicotine replacement. QC participants will only receive occasional prompts to quit. The primary endpoint will be 6M of abstinence measured 18M after enrollment. Secondary endpoints will include point prevalent abstinence, smoking reduction, self-efficacy and satisfaction. We will also collect qualitative data from successful abstainers and reducers about decision making processes and intervention experiences.

Clinical Significance This project will address the potential role of smoking reduction in the treatment menu for smokers interested in quitting. This project examines mechanisms, methods and a "real world" application for reducing toxin exposure. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00309296
Study type	Interventional
Source	Minneapolis Veterans Affairs Medical Center
Contact
Status	Completed
Phase	N/A
Start date	November 2005
Completion date	December 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02694796` - Impact of Web and Smartphone-based Physical Activity Program on Physical Activity Level 12 Months After a Balneotherapy	N/A
Completed	`NCT02351648` - A Randomised Control Trial of a Transitional Care Model in Singapore General Hospital	N/A
Completed	`NCT00772733` - A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment	N/A
Completed	`NCT00126737` - Home-Based Exercise and Weight Control Program for Pain Control in Overweight Elderly With Osteoarthritis of the Knee	N/A
Completed	`NCT01719991` - Vulnerable Patients in Primary Care: Nurse Case Management and Self-management Support	N/A
Completed	`NCT00569595` - Improving Health Habits in Impoverished Populations	Phase 3
Completed	`NCT02487589` - Falls in Elderly and Telehealth: a Randomized Controlled Study	N/A
Recruiting	`NCT00172926` - Study on the Relationship Between Physical Constitution and Diseases	N/A
Completed	`NCT00222703` - Enhancing Tobacco Abstinence Following Hospitalization	N/A
Recruiting	`NCT05233917` - Dietary Metabolic Signatures in Health Study
Active, not recruiting	`NCT05247632` - Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study
Completed	`NCT02885129` - Development of the General Scale Observance for Chronic Diseases	N/A
Completed	`NCT01832064` - Active Living Tool Kit for Chronic Conditions	N/A
Completed	`NCT01625468` - Brief Interventions to Create Smoke-Free Home Policies in Low-Income Households	N/A
Completed	`NCT00341536` - Feasibility Study for Prospective Diet and Lifestyle Cohorts in Delhi, Kerala, and Kolkota, India
Not yet recruiting	`NCT06046326` - Evaluate the Effectiveness of a Virtual Community of Practice	N/A
Completed	`NCT06179238` - Urinary Catheter Self-care Management	N/A
Active, not recruiting	`NCT02637869` - Evaluating Community Health Centers' Adoption of a New Global Capitation Payment
Completed	`NCT02191111` - A Cluster-randomized Controlled Knowledge Translation Feasibility Study in Alberta Community Pharmacies	N/A
Completed	`NCT01372137` - First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94	Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.